Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 6
1997 4
1998 4
1999 7
2000 7
2001 6
2002 4
2003 6
2004 2
2005 5
2006 6
2007 5
2008 11
2009 11
2010 6
2011 4
2012 5
2013 3
2014 6
2015 8
2018 1
2021 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.
Hutchings M, Morschhauser F, Iacoboni G, Carlo-Stella C, Offner FC, Sureda A, Salles G, Martínez-Lopez J, Crump M, Thomas DN, Morcos PN, Ferlini C, Bröske AE, Belousov A, Bacac M, Dimier N, Carlile DJ, Lundberg L, Perez-Callejo D, Umaña P, Moore T, Weisser M, Dickinson MJ. Hutchings M, et al. Among authors: ferlini c. J Clin Oncol. 2021 Jun 20;39(18):1959-1970. doi: 10.1200/JCO.20.03175. Epub 2021 Mar 19. J Clin Oncol. 2021. PMID: 33739857 Free PMC article. Clinical Trial.
From Protein Communication to Drug Discovery.
Persico M, Di Dato A, Orteca N, Fattorusso C, Novellino E, Andreoli M, Ferlini C. Persico M, et al. Among authors: ferlini c. Curr Top Med Chem. 2015;15(20):2019-31. doi: 10.2174/1568026615666150519102257. Curr Top Med Chem. 2015. PMID: 25986690 Review.
Class III β-tubulin in normal and cancer tissues.
Mariani M, Karki R, Spennato M, Pandya D, He S, Andreoli M, Fiedler P, Ferlini C. Mariani M, et al. Among authors: ferlini c. Gene. 2015 Jun 1;563(2):109-14. doi: 10.1016/j.gene.2015.03.061. Epub 2015 Apr 1. Gene. 2015. PMID: 25839941 Free PMC article. Review.
New taxanes in development.
Ferlini C, Gallo D, Scambia G. Ferlini C, et al. Expert Opin Investig Drugs. 2008 Mar;17(3):335-47. doi: 10.1517/13543784.17.3.335. Expert Opin Investig Drugs. 2008. PMID: 18321233 Review.
βIII-Tubulin: biomarker of taxane resistance or drug target?
Karki R, Mariani M, Andreoli M, He S, Scambia G, Shahabi S, Ferlini C. Karki R, et al. Among authors: ferlini c. Expert Opin Ther Targets. 2013 Apr;17(4):461-72. doi: 10.1517/14728222.2013.766170. Epub 2013 Feb 2. Expert Opin Ther Targets. 2013. PMID: 23379899 Review.
Novel drugs targeting microtubules: the role of epothilones.
Ferrandina G, Mariani M, Andreoli M, Shahabi S, Scambia G, Ferlini C. Ferrandina G, et al. Among authors: ferlini c. Curr Pharm Des. 2012;18(19):2793-803. doi: 10.2174/138161212800626238. Curr Pharm Des. 2012. PMID: 22390763 Review.
115 results